Effect of oral linezolid on the pressor response to intravenous tyramine

British Journal of Clinical Pharmacology

Volumn 58, Issue 5, 2004, Pages 470-475

  Cantarini, Mireille V ^a   Painter, Catherine J ^a   Gilmore, Elaine M ^a   Bolger, Catherine ^a   Watkins, Claire L ^a   Hughes, Andrew M ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Linezolid; Monoamine oxidase inhibitor; Tyramine pressor test

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; LINEZOLID; MOCLOBEMIDE; MONOAMINE OXIDASE A INHIBITOR; PHENTOLAMINE; TYRAMINE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG SAFETY; HEART BLOCK; HUMAN; KIDNEY COLIC; MALE; NORMAL HUMAN; PARESTHESIA; PRESSOR RESPONSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINUS BRADYCARDIA;

ACETAMIDES; ADMINISTRATION, ORAL; ADULT; BLOOD PRESSURE; BODY MASS INDEX; CROSS-OVER STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITORS; OXAZOLIDINONES; TYRAMINE;

EID: 9144239878     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.02186.x     Document Type: Article

References (22)

1. Lefkowitz RL, Hoffman BB, Taylor P. The autonomic and somatic motor nervous systems. In The Pharmacological Basis of Therapeutics, 10th edn, eds Hardman JG, Limbird LE. New York: McGrawHill, 2001; 105-39.
2. Korn A, Wagner B, Moritz E, Dingemanse J. Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline. Eur J Clin Pharmacol 1996; 49: 273-8.
3. Chose K. Tyramine pressor test: implications and limitations. Meth Find Exp Clin Pharmacol 1984; 6: 455-64.
4. Humphrey SJ, Curry JT, Turman CN, Stryd RP. Cardiovascular sympathomimetic amine interactions in rats treated with monoamine oxidase inhibitors and the novel oxazolidinone antibiotic linezolid. J Cardiovasc Pharmacol 2001; 37: 548-63.
5. Antal EJ, Hendershot PE, Batts DH, Sheu W-P, Hopkins NK, Donaldson KM. Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine. J Clin Pharmacol 2001; 41: 552-62.
6. Cesura AM, Kettler R, Imhof R, Da Prada M. Mode of action and characterisation of monoamine oxidase-A inhibition by moclobemide. Psychopharmacology (Berl) 1992; 106: S15-16.
7. Cusson JR, Goldenberg E, Larochelle P. Effect of a novel monoamine-oxidase inhibitor, moclobemide on the sensitivity to intravenous tyramine and norepinephrine in humans. J Clin Pharmacol 1991; 31: 462-7.
8. Pickering TG, Harshfield GA, Kleinert HD, Blank S, Laragh JH. Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA 1982; 247: 992-6.
9. Dingemanse J, Wood N, Guentert T, Øie S, Ouwerkerk M, Amrein R. Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects. Psychopharmacology 1998; 140: 164-72.
10. Mayersohn M, Guentert TW. Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide. Clin Pharmacokinet 1995; 29: 292-332.
11. Diekema DJ, Jones RN. Oxazolidinone antibiotics. Lancet 2001; 358: 1975-82.
12. Bieck PR, Firkusny L, Schick C et al. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers. Clin Pharmacol Ther 1989; 45: 260-9.
13. Hinze C, Kaschube M, Hardenberg J. Pharmacodynamics of MDL 72974A: absence of effect on the pressor response to oral tyramine. J Neural Transm 1994; 41 (Suppl): 371-5.
14. Dingemanse J, Korn A, Pfefen J-P, Güntert TW. Biochemical effects of high single doses of moclobemide in man: correlation with plasma concentrations. Psychopharmacology 1992; 106: S46-8.
15. Provost J-C, Funck-Brentano C, Rovei V, D'Estanque J, Ego D, Jaillon P. Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects. Clin Pharmacol Ther 1992; 52: 384-93.
16. Hendershot PE, Antal EJ, Welshman IR, Batts DH, Hopkins NK. Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorphan HBr. J Clin Pharmacol 2001; 41: 563-72.
17. French G. Safety and tolerability of linezolid. J Antimicrob Chemother 2003; 51 (Suppl. S2): ii45-ii53.
18. Reimann IW, Firkusny L, Antonin KH, Bieck PR. Intravenous amine pressor test in healthy volunteers. Within- and between subject variances and sex differences. Eur J Clin Pharmacol 1992; 42: 137-41.
19. Pace DG, Reele SB, Rozik LM, Rogers-Phillips CA, Dabice JA, Givens SV. Evaluation of methods of administering tyramine to raise systolic blood pressure. Clin Pharmacol Ther 1988; 44: 137-44.
20. Sundberg S, Gordin A. COMT inhibition with nitecapone does not affect the tyramine pressor response. Br J Clin Pharmacol 1991; 32: 130-2.
21. Wilkins MR, Wynne RD, Kendall MJ. A placebo controlled comparison of the effects of pirenzepine and amitriptyline on the tyramine pressor test in healthy volunteers. Br J Clin Pharmacol 1985; 19: 829-31.
22. Chose K, Gifford LA, Turner P, Leighton M. Studies of the interaction of desmethylimipramine with tyramine in man after a single oral dose, and its correlation with plasma concentration. Br J Clin Pharmacol 1976; 3: 334-7.